Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Ongoing genome doubling shapes evolvability and immunity in ovarian cancer

[thumbnail of Original Article]
Preview
PDF (Original Article) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
58MB
[thumbnail of Supplementary Information] Other (Supplementary Information)
43MB

Item Type:Article
Title:Ongoing genome doubling shapes evolvability and immunity in ovarian cancer
Creators Name:McPherson, Andrew, Vázquez-García, Ignacio, Myers, Matthew A., Al-Rawi, Duaa H., Zatzman, Matthew, Weiner, Adam C., Freeman, Samuel, Mohibullah, Neeman, Satas, Gryte, Williams, Marc J., Ceglia, Nicholas, Norkūnaitė, Danguolė, Zhang, Allen W., Li, Jun, Lim, Jamie L.P., Wu, Michelle, Choi, Seongmin, Havasov, Eliyahu, Grewal, Diljot, Shi, Hongyu, Kim, Minsoo, Schwarz, Roland F., Kaufmann, Tom, Dinh, Khanh Ngoc, Uhlitz, Florian, Tran, Julie, Wu, Yushi, Patel, Ruchi, Ramakrishnan, Satish, Kim, DooA, Clarke, Justin, Green, Hunter, Ali, Emily, DiBona, Melody, Varice, Nancy, Kundra, Ritika, Broach, Vance, Gardner, Ginger J., Roche, Kara Long, Sonoda, Yukio, Zivanovic, Oliver, Kim, Sarah H., Grisham, Rachel N., Liu, Ying L, Viale, Agnes, Rusk, Nicole, Lakhman, Yulia, Ellenson, Lora H., Tavaré, Simon, Aparicio, Samuel, Chi, Dennis S., Aghajanian, Carol, Abu-Rustum, Nadeem R., Friedman, Claire F., Zamarin, Dmitriy, Weigelt, Britta, Bakhoum, Samuel F. and Shah, Sohrab P.
Abstract:Whole-genome doubling (WGD) is a common feature of human cancers and is linked to tumour progression, drug resistance, and metastasis1,2,3,4,5,6. Here we examine the impact of WGD on somatic evolution and immune evasion at single-cell resolution in patient tumours. Using single-cell whole-genome sequencing, we analysed 70 high-grade serous ovarian cancer samples from 41 patients (30,260 tumour genomes) and observed near-ubiquitous evidence that WGD is an ongoing mutational process. WGD was associated with increased cell–cell diversity and higher rates of chromosomal missegregation and consequent micronucleation. We developed a mutation-based WGD timing method called doubleTime to delineate specific modes by which WGD can drive tumour evolution, including early fixation followed by considerable diversification, multiple parallel WGD events on a pre-existing background of copy-number diversity, and evolutionarily late WGD in small clones and individual cells. Furthermore, using matched single-cell RNA sequencing and high-resolution immunofluorescence microscopy, we found that inflammatory signalling and cGAS-STING pathway activation result from ongoing chromosomal instability, but this is restricted to predominantly diploid tumours (WGD-low). By contrast, predominantly WGD tumours (WGD-high), despite increased missegregation, exhibited cell-cycle dysregulation, STING1 repression, and immunosuppressive phenotypic states. Together, these findings establish WGD as an ongoing mutational process that promotes evolvability and dysregulated immunity in high-grade serous ovarian cancer.
Keywords:Chromosomal Instability, DNA Copy Number Variations, Human Genome, Membrane Proteins, Molecular Evolution, Mutation, Nucleotidyltransferases, Ovarian Neoplasms, Signal Transduction, Single-Cell Analysis, Whole Genome Sequencing
Source:Nature
ISSN:0028-0836
Publisher:Nature Publishing Group
Volume:644
Number:8078
Page Range:1078-1087
Date:28 August 2025
Official Publication:https://doi.org/10.1038/s41586-025-09240-3
PubMed:View item in PubMed
Related to:

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library